To combat severe domestic shortages driven by surging platinum and API costs, the NPPA has approved a one-time 50% price…
India’s domestic pharmaceutical market hit ₹21,805 crore in sales for May 2026, marking a 10.9% year-on-year increase.
The USFDA approval of Zaynich caps a high-risk journey in antibiotic research
Wockhardt’s novel antibiotic Zaynich has secured landmark US FDA approval to combat drug-resistant superbugs, potentially shifting the Indian pharmaceutical industry…
A new Department of Pharmaceuticals study shows strong consumer backing and financial viability for the Jan Aushadhi generic drug scheme,…
Medicines meant for treatment of diabetes, heart conditions set to get cheaper
Lord’s Mark unveils indigenous smart dialysis ecosystem
Danish pharma giant Novo Nordisk saw a 70% volume jump for Wegovy in April 2026 after slashing prices by up…
Apollo Hospitals’ Sangita Reddy outlines a pivot from episodic to continuous healthcare, leveraging AI and digital tools to detect early-onset…
Lord’s Mark Industries has received Central Licensing Authority approval to manufacture the LordsMed HIV 1&2 Self Test.
Dr. Reddy’s Laboratories (DRL) has secured Health Canada’s first-ever generic Semaglutide approval, targeting the world’s second-largest market for the diabetes…
Healthcare is moving from digital adoption to intelligence adoption. By integrating AI into clinical, operational, and administrative workflows, providers are…
The Indian domestic pharmaceutical market grew to ₹2.46 lakh crore in FY26, fueled by a 13.6% jump in the cardiac…
The expiration of Novo Nordisk’s semaglutide patent on March 20, 2026, has triggered a massive shift in India’s ₹1,600 crore…
Emcure Pharmaceuticals has announced a massive 55% price cut for Poviztra, its semaglutide weight-management drug in India.
The Confederation of Indian Industry (CII) has petitioned the Department of Pharmaceuticals for freight subsidies and drug pricing relaxations as…
Pune-based startup CureMeAbroad is revolutionizing medical tourism with an AI-driven discovery platform for high-value patients from the US, UK, and…
While NATHEALTH reports a stable outlook for Indian hospitals amid the West Asia conflict, medical device manufacturers (AiMeD) are seeking…